Los Angeles, CA, United States of America

Liqin Zhao

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: University of Southern California. Active years: 2013-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liqin Zhao. Retrieved from https://idiyas.com/inventor/liqin-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Liqin Zhao

Introduction

Liqin Zhao is a notable inventor based in Los Angeles, California, recognized for his contributions to the field of phytoestrogenic formulations. With a total of two patents, his work focuses on alleviating menopausal symptoms and promoting neurological health.

Latest Patents

Liqin Zhao's latest patents include innovative formulations aimed at addressing menopausal symptoms and neurodegenerative diseases. The first patent describes select phytoestrogen pharmaceutical compositions that are designed to prevent or reduce symptoms associated with pre-menopause, menopause, and post-menopause. These formulations consist of two or more plant-derived estrogenic molecules that preferentially bind to estrogen receptor beta (ERβ) over estrogen receptor alpha (ERα). They exhibit agonist activity in the brain and are capable of crossing the blood-brain barrier, promoting neurotrophism and neuroprotection without activating proliferative mechanisms in reproductive tissues. The formulations can be administered through various routes, including enterally, transdermally, and intranasally, and are particularly beneficial for women early in menopause.

The second patent focuses on select phytoestrogen formulations for promoting neurological health and preventing age-related neurodegeneration, such as Alzheimer's Disease (AD). Similar to the first patent, these formulations are composed of plant-derived estrogenic molecules that exhibit a binding preference to ERβ. They also cross the blood-brain barrier and promote neuroprotection while avoiding problematic estrogen-associated effects. These formulations are designed to be administered in effective dosages to prevent neuronal damage and support neuronal regeneration.

Career Highlights

Liqin Zhao is affiliated with the University of Southern California, where he continues to advance research in the field of phytoestrogens and their applications in women's health and neurodegenerative diseases. His innovative work has the potential to significantly impact the quality of life for individuals experiencing menopausal symptoms and age-related cognitive decline.

Collaborations

Liqin Zhao collaborates with Roberta Diaz Brinton, a prominent figure in the field of neuroscience and women's health. Their partnership aims to enhance the understanding and development of phytoestrogenic formulations.

Conclusion

Liqin Zhao's contributions to the field of phytoestrogenic formulations represent significant advancements in addressing menopausal symptoms and promoting neurological health. His innovative patents reflect a commitment to improving the lives of individuals affected

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…